BAMF
WST icon

BI Asset Management Fondsmaeglerselskab’s West Pharmaceutical WST Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Sell
1,592
-3,623
-69% -$901K ﹤0.01% 567
2025
Q4 		$1.44M Buy
5,215
+336
+7% +$91.9K 0.01% 465
2025
Q3 		$1.28M Buy
4,879
+620
+15% +$151K 0.01% 473
2025
Q2 		$932K Buy
4,259
+2,240
+111% +$479K 0.01% 499
2025
Q1 		$452K Sell
2,019
-1,013
-33% -$279K 0.01% 580
2024
Q4 		$993K Sell
3,032
-1,131
-27% -$356K 0.01% 515
2024
Q3 		$1.25M Buy
4,163
+777
+23% +$238K 0.02% 353
2024
Q2 		$1.11M Buy
3,386
+77
+2% +$27.2K 0.02% 377
2024
Q1 		$1.31M Buy
3,309
+1,348
+69% +$499K 0.02% 316
2023
Q4 		$691K Sell
1,961
-241
-11% -$85.3K 0.01% 465
2023
Q3 		$826K Buy
2,202
+148
+7% +$57.2K 0.02% 406
2023
Q2 		$786K Buy
2,054
+67
+3% +$23.9K 0.02% 398
2023
Q1 		$688K Buy
1,987
+651
+49% +$190K 0.02% 400
2022
Q4 		$314K Buy
+1,336
New +$317K 0.01% 474
2022
Q3 		– Sell
-530
Closed -$160K – 494
2022
Q2 		$160K Buy
+530
New +$172K 0.01% 429
2020
Q4 		– Sell
-3,972
Closed -$1.09M – 497
2020
Q3 		$1.09M Buy
3,972
+1,794
+82% +$475K 0.05% 271
2020
Q2 		$495K Buy
+2,178
New +$428K 0.03% 348
2020
Q1 		– Sell
-11,649
Closed -$1.75M – 391
2019
Q4 		$1.75M Sell
11,649
-7,905
-40% -$1.15M 0.08% 208
2019
Q3 		$2.77M Buy
+19,554
New +$2.69M 0.14% 136

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's WST Position: Q1 2026 in Review

BI Asset Management Fondsmaeglerselskab reduced its West Pharmaceutical (WST) stake by 69% in Q1 2026, selling an estimated $901K and leaving 1,592 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #567.

BI Asset Management Fondsmaeglerselskab first reported a position in WST in Q3 2019 and has held it in 19 quarters since. The position peaked at $2.77M in Q3 2019. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • BI Asset Management Fondsmaeglerselskab held 1,592 shares of West Pharmaceutical worth $399K as of Q1 2026.
  • BI Asset Management Fondsmaeglerselskab sold 3,623 West Pharmaceutical shares in Q1 2026, an estimated $901K.
  • West Pharmaceutical made up ﹤0.01% of BI Asset Management Fondsmaeglerselskab's portfolio in Q1 2026, its #567 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in West Pharmaceutical in Q3 2019 and has held it in 19 quarters since.
  • BI Asset Management Fondsmaeglerselskab's West Pharmaceutical position peaked at $2.77M in Q3 2019.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q1 2026, filed 16 Apr 2026.